Monte Rosa Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Monte Rosa Therapeutics, Inc. (GLUE) had Common Stock, Capital Shares Reserved for Future Issuance of 33.60 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 33.60M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 34.14M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 35.48M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 36.36M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 33.60M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 34.14M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 35.48M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 36.36M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 36.61M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 36.69M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 32.34M shares 10-K · filed 2026-03-17 | |
| 2024-09-30 | 32.34M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 32.33M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 11.96M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 19.65M shares 10-K · filed 2025-03-20 | 9.65M shares 10-Q · filed 2024-05-09 |
| 2023-09-30 | 9.76M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 10.25M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 10.28M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 7.65M shares 10-Q · filed 2023-11-09 | |
| 2022-09-30 | 7.45M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 7.38M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 7.33M shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | 5.82M shares 10-Q · filed 2022-11-10 | |
| 2021-09-30 | 5.86M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 5.99M shares 10-Q · filed 2021-08-12 | |
| 2020-12-31 | 56.33M shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |